President Joe Biden has signed an executive order to further bolster the country’s manufacturing capacity.
This time the focus is the biotech sector and the goal is to make sure that what’s invented in the U.S. is also made there to allow for affordable costs for American consumers.
According to the White House investments into the biotech sector will be expanded and an actual sum will be shared this week.
Pundits meanwhile believe this latest initiative may lead to repercussions for South Korea as the U.S. seeks to ease its external reliance.
